Hives and angioedema


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Risk factors

By Mayo Clinic staff

Hives and angioedema are common. You may be at increased risk of hives and angioedema if you:

  • Have had hives or angioedema before
  • Have had other allergic reactions
  • Have a disorder associated with hives and angioedema, such as lupus, lymphoma or thyroid disease
  • Have a family history of hives, angioedema or hereditary angioedema
Complications Causes
References
  1. Kaplan AP. Urticaria and angioedema. In: Wolff K, et al. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, N.Y.: The McGraw-Hill Companies; 2008. http://www.accessmedicine.com/content.aspx?aid=2958607. Accessed Sept. 13, 2010.
  2. MacNeal RJ. Urticaria. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec10/ch109/ch109e.html?qt=urticaria&alt=sh#sec10-ch109-ch109e-101c. Accessed Sept. 14, 2010.
  3. Bingham CO. New onset urticaria: Diagnosis and Treatment. http://www.uptodate.com/home/index.html. Accessed Sept. 29, 2010.
  4. Atkinson JP. Diagnosis of hereditary angioedema. http://www.uptodate.com/home/index.html. Accessed Sept. 29, 2010.
  5. Bingham CO. New onset urticaria: Epidemiology, clinical manifestations and etiology. http://www.uptodate.com/home/index.html. Accessed Sept. 29, 2010.
  6. Urticaria and angioedema. In: Wolff K, et al. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology. 6th ed. New York, N.Y. The McGraw-Hill Companies; 2009. http://www.accessmedicine.com/content.aspx?aID=5187962. Accessed Sept. 14, 2010.
  7. Initial evaluation of all patients with urticaria. In: Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, Scotland. Mosby/Elsevier; 2010. http://www.mdconsult.com/books/page.do?eid=4-u1.0-B978-0-7234-3541-9..00015-8--s0180&isbn=978-0-7234-3541-9&type=bookPage&sectionEid=4-u1.0-B978-0-7234-3541-9..00015-8--s0180&uniqId=220753099-3#4-u1.0-B978-0-7234-3541-9..00015-8--s0180. Accessed Oct. 1, 2010.
  8. Treatment of urticaria. In: Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, Scotland. Mosby/Elsevier; 2010. http://www.mdconsult.com/books/page.do?eid=4-u1.0-B978-0-7234-3541-9..00015-8--s0290&isbn=978-0-7234-3541-9&type=bookPage&sectionEid=4-u1.0-B978-0-7234-3541-9..00015-8--s0290&uniqId=220753099-3#4-u1.0-B978-0-7234-3541-9..00015-8--s0290. Accessed Sept. 13, 2010.
  9. Acute urticaria: Evaluation and management. In: Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 5th ed. Edinburgh, Scotland. Mosby/Elsevier; 2010. http://www.mdconsult.com/books/page.do?eid=4-u1.0-B978-0-7234-3541-9..00015-8--s0185&isbn=978-0-7234-3541-9&type=bookPage&sectionEid=4-u1.0-B978-0-7234-3541-9..00015-8--s0185&uniqId=220753099-3#4-u1.0-B978-0-7234-3541-9..00015-8--s0185. Accessed Oct. 1, 2010.
  10. Bingham CO. An overview of angioedema: Clinical features, diagnosis and management. http://www.uptodate.com/index/home.html. Accessed Oct. 1, 2010.
  11. Delves PJ. Angioedema. The Merck Manuals: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec13/ch165/ch165b.html. Accessed Oct. 1, 2010.
  12. FDA licenses for marketing new drug for rare genetic disease. Food and Drug Administration. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm161477.htm. Accessed Oct. 1, 2010.
  13. Cinryze. Food and Drug Administration. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm150480.htm. Accessed Oct. 6, 2010.
  14. Nolte H, et al. Overview of skin testing for allergic disease. http://www.uptodate.com/index/home.html. Accessed Oct. 2, 2010.
  15. Berinert. Food and Drug Administration. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm186264.htm. Accessed Oct. 15, 2010.
  16. Kalbitor. Drugs @FDA. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. Accessed Oct. 15, 2010.
  17. Gibson LE (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 13, 2010.
DS00313 Dec. 21, 2010

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print

  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger